Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $64.3800 (0.05%) ($62.5200 - $65.0000) on Wed. Oct. 25, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0.77% (three month average) | RSI | 64 | Latest Price | $64.3800(0.05%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX advances 0.2% a day on average for past five trading days. | Weekly Trend | BAX advances 1.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(58%) SPLV(53%) VYM(52%) IVE(50%) IWD(50%) | Factors Impacting BAX price | BAX will decline at least -0.385% in a week (0% probabilities). TLT(-19%) VIXM(-16%) GDXJ(-9%) UUP(-6%) DIA(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.385% (StdDev 0.77%) | Hourly BBV | 0 () | Intraday Trend | 1.8% | | | |
|
5 Day Moving Average | $63.98(0.63%) | 10 Day Moving Average | $63.7(1.07%) | 20 Day Moving Average | $63.1(2.03%) | To recent high | -0.4% | To recent low | 8.2% | Market Cap | $32.846b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |